Sex | Localisation | Observed | Expected | SIR |
---|---|---|---|---|
(95% CI) | ||||
Men | Anal canal | 1 | 0.53 | 1.90 (0.02 to 10.6) |
Biliary tract | 4 | 1.41 | 2.84 (0.76 to 7.26) | |
Colon–rectum | 33 | 25.9 | 1.27 (0.87 to 1.79) | |
Stomach | 12 | 9.09 | 1.32 (0.68 to 2.31) | |
Liver | 18 | 9.75 | 1.85 (1.09 to 2.92) | |
Small intestine | 3 | 0.67 | 4.47 (0.90 to 13.1) | |
Peritoneum | 3 | 0.23 | 13.3 (2.67 to 38.8) | |
Oesophagus | 25 | 14.9 | 1.67 (1.08 to 2.47) | |
Other | 0 | 0.54 | NC | |
Pancreas | 7 | 5.66 | 1.24 (0.49 to 2.55) | |
Digestive excluding mesothelioma | 103 | 68.5 | 1.50 (1.23 to 1.82) | |
All digestive | 106 | 68.5 | 1.55 (1.27 to 1.85) | |
Women | Anal canal | 0 | 0.29 | NC |
Biliary tract | 0 | 0.39 | NC | |
Colon–rectum | 6 | 4.49 | 1.33 (0.49 to 2.91) | |
Stomach | 1 | 1.00 | 0.99 (0.01 to 5.54) | |
Liver | 1 | 0.39 | 2.55 (0.03 to 14.2) | |
Small intestine | 0 | 0.12 | NC | |
Peritoneum | 5 | 0.12 | 43.0 (13.9 to 100) | |
Oesophagus | 0 | 0.33 | NC | |
Other | 0 | 0.10 | NC | |
Pancreas | 0 | 0.92 | NC | |
Digestive excluding mesothelioma | 8 | 8.04 | 0.99 (0.43 to 1.96) | |
All digestive | 13 | 8.18 | 1.59 (0.84 to 2.72) |
NC, non-calculated; SIR, Standardised Incidence Ratio.